Company news

Sutro Biopharma, Inc. news in 2026

Sutro Biopharma, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Sutro Biopharma to Participate in Upcoming Investor Conferences

November 4, 2026

Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors

October 21, 2026

Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference

October 12, 2026

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

September 29, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

August 12, 2026

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

May 14, 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

April 19, 2026

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

March 22, 2026

Sutro Biopharma Announces Participation at the 16th World ADC London Summit

February 23, 2026

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

February 10, 2026

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026

Decks in 2026